These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2977177)
1. Dopaminergic-opioidergic interaction is reflected by changes in pituitary hormone secretion in patients with essential hypertension. Alföldi A; Kárteszi M; Simkó K; Farsang C J Hypertens Suppl; 1988 Dec; 6(4):S387-8. PubMed ID: 2977177 [TBL] [Abstract][Full Text] [Related]
2. Metoclopramide decreases baroreflex sensitivity in patients with essential hypertension. Alföldi A; Farsang C Life Sci; 1987 Apr; 40(15):1469-72. PubMed ID: 3561160 [TBL] [Abstract][Full Text] [Related]
3. The role of opiate, dopaminergic, and adrenergic systems in the hypothalamo-pituitary dysfunction in obesity. Baranowska B; Singh SP; Soszynski P; Nowakowski J; Jeske W Acta Endocrinol (Copenh); 1987 Oct; 116(2):221-8. PubMed ID: 2889310 [TBL] [Abstract][Full Text] [Related]
4. Evidence for decreased endogenous dopamine and opioid inhibitory influences on LH secretion in polycystic ovary syndrome. Cumming DC; Reid RL; Quigley ME; Rebar RW; Yen SS Clin Endocrinol (Oxf); 1984 Jun; 20(6):643-8. PubMed ID: 6088126 [TBL] [Abstract][Full Text] [Related]
5. Dopaminergic regulation of alpha-melanocyte-stimulating hormone and N-acetyl-beta-endorphin secretion in the fetal lamb. Newman CB; Wardlaw SL; Stark RI; Daniel SS; Frantz AG Endocrinology; 1987 Mar; 120(3):962-6. PubMed ID: 3803322 [TBL] [Abstract][Full Text] [Related]
6. Effects of a dopamine antagonist (metoclopramide) on the release of beta-endorphin, ACTH and cortisol in hyperprolactinemic-amenorrheic women. Seki K; Mitsui C; Nagata I Gynecol Obstet Invest; 1995; 40(1):42-5. PubMed ID: 7557642 [TBL] [Abstract][Full Text] [Related]
7. Experimental pain thresholds and plasma beta-endorphin levels during exercise. Droste C; Greenlee MW; Schreck M; Roskamm H Med Sci Sports Exerc; 1991 Mar; 23(3):334-42. PubMed ID: 2020272 [TBL] [Abstract][Full Text] [Related]
8. Reexamination of the role of endogenous opiates in silent myocardial ischemia. Marchant B; Umachandran V; Wilkinson P; Medbak S; Kopelman PG; Timmis AD J Am Coll Cardiol; 1994 Mar; 23(3):645-51. PubMed ID: 8113547 [TBL] [Abstract][Full Text] [Related]
9. Opioidergic inhibition of circulatory and endocrine stress responses in cynomolgus monkeys: a preliminary study. McCubbin JA; Kaplan JR; Manuck SB; Adams MR Psychosom Med; 1993; 55(1):23-8. PubMed ID: 8383349 [TBL] [Abstract][Full Text] [Related]
10. Evidences for a dopamine-regulated peripheral source of circulating beta-endorphin. Genazzani AR; Petraglia F; Facchinetti F; Golinelli S; Oltramari P; Santoro V; Volpe A J Clin Endocrinol Metab; 1988 Feb; 66(2):279-82. PubMed ID: 2963016 [TBL] [Abstract][Full Text] [Related]
12. Altered pituitary hormone response to naloxone in hypertension development. McCubbin JA; Surwit RS; Williams RB; Nemeroff CB; McNeilly M Hypertension; 1989 Dec; 14(6):636-44. PubMed ID: 2555303 [TBL] [Abstract][Full Text] [Related]
13. Dopaminergic mediation of beta-endorphin-induced prolactin secretion. Van Loon GR; De Souza EB; Shin SH Neuroendocrinology; 1980 Oct; 31(4):293-6. PubMed ID: 6252497 [TBL] [Abstract][Full Text] [Related]
14. Naloxone effects on beta-endorphin, cortisol, prolactin, growth hormone, HVA and MHPG in plasma of normal volunteers. Naber D; Pickar D; Davis GC; Cohen RM; Jimerson DC; Elchisak MA; Defraites EG; Kalin NH; Risch SC; Buchsbaum MS Psychopharmacology (Berl); 1981; 74(2):125-8. PubMed ID: 6267643 [TBL] [Abstract][Full Text] [Related]
15. Endogenous opioid system and atrial natriuretic factor in normotensive offspring of hypertensive parents at rest and during exercise test. Fontana F; Bernardi P; Merlo Pich E; Boschi S; De Iasio R; Capelli M; Carboni L; Spampinato S J Hypertens; 1994 Nov; 12(11):1285-90. PubMed ID: 7868876 [TBL] [Abstract][Full Text] [Related]
16. Increases in plasma beta-endorphin concentrations during exercise do not contribute to increases in heart rate following autonomic blockade in man. Shen A; Chin J; Fullerton M; Jennings G; Dart A Br J Clin Pharmacol; 1992 Jan; 33(1):89-92. PubMed ID: 1540495 [TBL] [Abstract][Full Text] [Related]
17. Beta-endorphin immunoreactivity during high-intensity exercise with and without opiate blockade. Angelopoulos TJ Eur J Appl Physiol; 2001 Nov; 86(1):92-6. PubMed ID: 11820329 [TBL] [Abstract][Full Text] [Related]
18. The effect of naloxone and metoclopramide on the secretion of luteinizing hormone in a hyperprolactinemic hypogonadotropic postmenopausal woman. Verhelst J; Beckers A; Abs R Fertil Steril; 1995 Nov; 64(5):969-71. PubMed ID: 7589643 [TBL] [Abstract][Full Text] [Related]
19. Acute dopaminergic blockade augments the naloxone-induced LH rise in estrogen-treated postmenopausal women. Parra A; Barrón J; Marín VA; Coutiño B; Belmont J; Coria I Maturitas; 1997 May; 27(1):91-9. PubMed ID: 9158083 [TBL] [Abstract][Full Text] [Related]
20. Asymptomatic or mildly symptomatic effort-induced myocardial ischemia: plasma beta-endorphin and effect of naloxone. Cantor A; Shapiro Y; Eyal A; Gueron M; Danon A Isr J Med Sci; 1990 Feb; 26(2):67-71. PubMed ID: 2138595 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]